PR

Prime Medicine IncNASDAQ PRME Stock Report

Last reporting period 30 Sep, 2024

Updated 18 Nov, 2024

Last price

Market cap $B

1.45

Small

Exchange

XNAS - Nasdaq

View Section: Price ratios

Prime Statements

PR

Data from Prime`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

USD - US dollar

Last reporting period:

30 Sep, 2024

Next reporting period:

29 Dec, 2024

Report frequency:

Quarterly

Earnings release date:

Expected release date:

01 Nov, 2024

Prime Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

USD (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2024-09-30
%

0.209

100

0

0

40.34

19301.4

14.101

6746.9

54.441

-2.2 %

26048.3

-54.232

2.6 %

-25948.3

1.797

859.8

-0.083

-39.7

-52.518

5.3 %

-25128.2

0

-52.518

5.1 %

-25128.2

-0.439

119.76

2024-06-30
%

-100 %

100

0

0

43.071

0

12.601

0

55.672

13.8 %

0

-55.672

-15.2 %

0

0.172

0

0.039

0

-55.461

-21.6 %

0

-0.134

0

-55.327

-20.9 %

0

-0.464

119.19

2024-03-31
%

0.591

100

0

0

37.774

6391.5

11.158

1888

48.932

-28.1 %

8279.5

-48.341

29 %

-8179.5

1.166

197.3

1.548

261.9

-45.627

30.5 %

-7720.3

0.134

22.7

-45.761

30.3 %

-7743

-0.438

104.47

2023-12-31
%

100

0

0

41.459

0

13.084

0

68.043

32.2 %

0

-68.043

-32.2 %

0

0.635

0

1.765

0

-65.643

-29.2 %

0

0

-65.643

-29.4 %

0

-0.71

92.468

2023-09-30
%

100

0

0

40.97

0

10.49

0

51.46

13.7 %

0

-51.46

-13.7 %

0

-1.58

0

2.22

0

-50.82

-20 %

0

-0.11

0

-50.71

-19.6 %

0

-0.55

91.85

2023-06-30
%

100

0

0

34.6

0

10.66

0

45.26

13.1 %

0

-45.26

-13.1 %

0

0.26

0

2.64

0

-42.35

-6.9 %

0

0.03

0

-42.39

-7.6 %

0

-0.47

90.47

2023-03-31
%

100

0

0

30.88

0

9.15

0

40.03

3.5 %

0

-40.03

-3.5 %

0

-1.7

0

2.14

0

-39.6

-0.3 %

0

-0.2

0

-39.4

3 %

0

-0.44

89.06

2022-12-31
%

100

0

0

29.06

0

9.63

0

38.69

22.2 %

0

-38.69

-22.2 %

0

-1.71

0

0.93

0

-39.47

-35.4 %

0

-0.19

0

-40.6

-13.7 %

0

-0.38

105.83

2022-09-30
%

100

0

0

25.05

0

6.61

0

31.66

20.3 %

0

-31.66

-20.3 %

0

1.79

0

0.73

0

-29.14

2.2 %

0

0.21

0

-35.71

-0.2 %

0

-0.38

94.34

2022-06-30
%

100

0

0

18.94

0

7.37

0

26.31

32.2 %

0

-26.31

-32.2 %

0

-3.72

0

0.24

0

-29.79

-22.2 %

0

-0.44

0

-35.64

-18.6 %

0

-0.38

94.34

2022-03-31
%

100

0

0

13.68

0

6.22

0

19.9

-66.9 %

0

-19.9

66.9 %

0

-4.49

0

0.01

0

-24.37

60.4 %

0

-0.53

0

-30.06

56.6 %

0

-0.32

94.34

2021-12-31
%

100

0

0

52.89

0

7.19

0

60.08

476 %

0

-60.08

-476 %

0

-1.47

0

0.01

0

-61.53

-227.6 %

0

1.38

0

-69.27

-204.1 %

0

-0.73

94.34

2021-09-30
%

100

0

0

7.4

0

3.03

0

10.43

0

-10.43

0

-8.35

0

0

-18.78

0

-2.37

0

-22.78

0

-0.24

94.34

View Section: Balance Sheet